Abstract
No abstract available
Funding Information
  • Japan Society for the Promotion of Science (JP21H02902)
  • Japan Society for the Promotion of Science (JP24K18971)
  • Fusion Oriented REsearch for disruptive Science and Technology (23719768)
  • Japan Agency for Medical Research and Development (24ama221326h0002)
  • Japan Agency for Medical Research and Development (23ama221326h0001)
  • Japan Agency for Medical Research and Development (22cm0106283h0002)
  • Astellas Pharma
  • Princess Takamatsu Cancer Research Fund
  • Co-creation place formation support program (JPMJPF2018)
  • Takeda Science Foundation